An official website of the United States government
Publication Information
Affiliation
Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, CA.; Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, CA.; Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, CA.; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.; Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, CA.
Authors
Fallahzadeh Mohammad Kazem, Ku Elaine, Chu Chi D, McCulloch Charles E, Tuot Delphine S
Studies
Abstract
Black kidney transplant recipients have higher prevalences of cardiovascular disease (CVD) risk factors and less intensive risk factor control than White kidney transplant recipients. Our objective was to evaluate racial disparities in receipt of statins and aspirin for secondary CVD prevention among kidney transplant recipients in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) trial.